CARBONARA, Giuseppe Gerardo
 Distribuzione geografica
Continente #
NA - Nord America 4.535
AS - Asia 1.908
EU - Europa 1.399
SA - Sud America 486
AF - Africa 61
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.400
Nazione #
US - Stati Uniti d'America 4.465
SG - Singapore 752
CN - Cina 482
BR - Brasile 397
SE - Svezia 255
HK - Hong Kong 242
UA - Ucraina 172
IT - Italia 170
FR - Francia 166
DE - Germania 161
RU - Federazione Russa 155
FI - Finlandia 116
VN - Vietnam 104
GB - Regno Unito 95
IN - India 92
BD - Bangladesh 37
CA - Canada 31
AR - Argentina 26
IR - Iran 26
TR - Turchia 25
CI - Costa d'Avorio 22
IQ - Iraq 22
MX - Messico 22
ID - Indonesia 19
IE - Irlanda 18
CO - Colombia 17
BE - Belgio 15
SA - Arabia Saudita 15
EC - Ecuador 12
ES - Italia 12
JP - Giappone 12
ZA - Sudafrica 12
PH - Filippine 11
CZ - Repubblica Ceca 10
NL - Olanda 9
PK - Pakistan 9
VE - Venezuela 9
AU - Australia 8
CL - Cile 8
CH - Svizzera 7
JM - Giamaica 7
KR - Corea 7
LT - Lituania 7
MY - Malesia 7
UZ - Uzbekistan 7
PE - Perù 6
DZ - Algeria 5
JO - Giordania 5
RO - Romania 5
AT - Austria 4
IL - Israele 4
KE - Kenya 4
KG - Kirghizistan 4
MA - Marocco 4
NP - Nepal 4
PL - Polonia 4
RS - Serbia 4
UY - Uruguay 4
BO - Bolivia 3
EG - Egitto 3
HN - Honduras 3
PS - Palestinian Territory 3
PY - Paraguay 3
A1 - Anonimo 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
DK - Danimarca 2
GE - Georgia 2
KW - Kuwait 2
KZ - Kazakistan 2
MM - Myanmar 2
OM - Oman 2
SN - Senegal 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
Totale 8.394
Città #
Ashburn 407
Jacksonville 393
Fairfield 378
Chandler 369
Woodbridge 362
Singapore 345
Hong Kong 237
San Jose 230
Houston 221
Cambridge 185
Nyköping 182
Ann Arbor 171
Seattle 143
Wilmington 130
Beijing 104
Nanjing 93
Dallas 91
Lawrence 88
Roxbury 88
Lauterbourg 75
Princeton 67
Bari 64
Boardman 64
Des Moines 59
Los Angeles 51
New York 45
Ho Chi Minh City 42
Inglewood 40
São Paulo 33
Marseille 32
Santa Clara 28
Munich 25
Brooklyn 24
Buffalo 24
Council Bluffs 24
Nanchang 24
Helsinki 23
Abidjan 22
Hanoi 21
Jiaxing 21
Hebei 20
Tianjin 19
Dublin 18
Chicago 17
Changsha 16
Orem 16
Brussels 15
San Diego 15
London 14
Mumbai 14
Rio de Janeiro 14
Toronto 14
Chennai 13
Shenyang 13
Paris 12
San Francisco 12
Tokyo 12
Washington 12
Frankfurt am Main 11
Guangzhou 11
Istanbul 11
Rome 11
Augusta 10
Brasília 10
Leawood 10
Belo Horizonte 9
Mexico City 9
Stockholm 9
Baghdad 8
Dearborn 8
Long Beach 8
Ardabil 7
Dhaka 7
Jeddah 7
Johannesburg 7
Lausanne 7
Manchester 7
Medellín 7
North Bergen 7
San Mateo 7
Shanghai 7
Tashkent 7
Turku 7
Wuhan 7
Atlanta 6
Boydton 6
Delhi 6
Haikou 6
Jakarta 6
Poplar 6
Porto Alegre 6
Quito 6
Amman 5
Amsterdam 5
Auburn Hills 5
Boston 5
Buenos Aires 5
Caracas 5
Caxias do Sul 5
Curitiba 5
Totale 5.595
Nome #
Probiotic and Tea Tree Oil Treatments Improve Therapy of Vaginal Candidiasis: A Preliminary Clinical Study 234
An efficient synthesis of the optically active isomers of 2H-1,4-benzoxazine derivatives, novel KATP channel modulators 204
Activation and inhibition of kidney CLC-K chloride channels by fenamates 184
Convenient synthesis of some 3-phenyl-1-benzofuran-2-carboxylic acid derivatives as new potential inhibitors of CLC-Kb channels 180
Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonists 174
Kidney CLC-K Chloride Channels Show Differential Pharmacological Profiles Depending on the Heterologous Expression System 168
Synthesis, biological evaluation, and molecular modeling investigation of chiral 2-(4-chloro-phenoxy)-3-phenyl-propanoic acid derivatives with PPARα and PPARγ agonist activity 153
ChemInform Abstract: Convenient Synthesis of Some 3-Phenyl-1-benzofuran-2-carboxylic Acid Derivatives as New Potential Inhibitors of CLC-Kb Channels. 151
Comparative LC Enantioseparation of Novel PPAR Agonists on Cellulose- and Amylose-Based Chiral Stationary Phases 151
2-(9-Antryl)alcanoic acids as chloride channel modulators 149
Carboxylic acids and skeletal muscle chloride channel conductance: Effects on the biological activity induced by the introduction of an aryloxyalkyl group α to the carboxylic function of 4-chloro-phenoxyacetic acid 149
Repositioning of Endonuclear Receptors Binders as Potential Antibacterial and Antifungal Agents. Eptyloxìm: A Potential and Novel Gyrase B and Cytochrome Cyp51 Inhibitor 136
Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+ - deficient rats 132
Kidney CLC-K Chloride Channels Inhibitors: Definition of Novel Structural Requirements and Efficacy in CLC-K Polymorphism Associated with Hypertension 123
Elucidation of the synergistic action of Mentha Piperita essential oil with common antimicrobials 123
AGONISTI DEI RECETTORI NUCLEARI PPARs COME POTENZIALI NUOVI AGENTI TERAPEUTICI PER IL TRATTAMENTO DELLA SINDROME METABOLICA. 122
Molecular determinants for the activating/blocking actions of the 2H-1,4-benzoxazine derivatives, a class of potassium channel modulators targeting the skeletal muscle KATP channels 120
(contributo in convegno) MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY; CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 120
Agonisti dei Recettori Nucleari PPARs come Potenziali Nuovi Agenti Terapeutici per il Trattamento della Sindrome Metabolica 118
Allyphenyline Analogues Potentially Useful in the Management of Chronic Pain and Opioid Addiction 114
MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY: CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 114
Comparative analysis of enantioselective separation of novel PPAR agonists by HPLC on cellulose- and amylose-based chiral stationary phases 114
Chemical studies on Drug Metabolism (part II): N-demethylation and N-oxidation of some alicyclic amines by RuO4 111
Synthesis, Biological Evaluation, and Molecular Modeling Investigation of Chiral Phenoxyacetic Acid Analogues with PPARalpha and PPARgamma Agonist Activity 111
Block of renal CLC-K channels by phenoxy-alkyl derivatives of clofibric acid 108
Analisi Farmaceutica 107
Enantiomeric separation of 2-aryloxyalkyl- and 2-arylalkyl-2-aryloxyacetic acids on a Penicillin G Acylase-based chiral stationary phase: influence of the chemical structure on retention and enantioselectivity 107
Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor alpha/gamma ligand LT175 106
Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms. 106
Attività biologica sui canali KATP del muscolo scheletrico nativo di nuovi e potenti derivati delle 2H-1,4-Benzossazine 104
Might the observed a2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? 104
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/non-peptidyl structure 103
KIDNEY CLC-K CHLORIDE CHANNELS SHOW DIFFERENTIAL PHARMACOLOGICAL PROFILES DEPENDING ON THE HETEROLOGOUS EXPRESSION SYSTEM 101
Elucidation of the enantioselective recognition mechanism of a penicillin G acylase-based chiral stationary phase towards a series of 2-aryloxy-2-arylacetic acids 95
BIOLOGICAL ACTIVITY OF NEW POTENT 2H-1,4-BENZOXAZINE DERIVATIVES ON THE NATIVE SKELETAL MUSCLE KATP CHANNEL 93
Exploring the molecular basis of the enantioselective binding of penicillin G acylase towards a series of 2 aryloxyalkanoic acids: A docking and molecular dynamics study 92
Calcium activated K+ channel as a target of prompt-to-use drugs in neuromuscular disorders 91
Sintesi di una nuova serie di acidi 2-benzofuran-carbossilici a potenziale attività bloccante dei canali al cloro voltaggio-dipendenti CLC-K 90
Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors alpha/gamma dual agonists 89
Structural nucleotide analogs are potent activators/inhibitors of pancreatic beta-cell KATP channels: an emerging mechanism supporting their use as anti-diabetic drugs. 87
Molecular determinants for nuclear receptors selectivity: chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors alpha/gamma agonists 87
INNOVATIVE METHODOLOGIES IN NANOTECHNOLOGY FOR THE PREVENTION OF BACTERIAL DISEASES 86
Molecular switch for CLC-K Cl– channel block/activation: Optimal pharmacophoric requirements towards high-affinity ligands 86
Studio delle proprietà enentioselettive di una fase stazionaria chirale a base di PGA 85
Ossidazione di ammine policicliche terziarie con RuO4 83
Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid 83
Chemical studies on Drug Metabolism: Oxidation with ruthenium tetroxide of some medicinal alicyclic N-metylamines 80
Selective oxidation of nitrogen organic compounds 78
SINTESI E VALUTAZIONE BIOLOGICA DI DERIVATI SEMI-RIGIDI DELL'ACIDO 2-(4-CLOROFENOSSI)-3-FENIL-PROPANOICO COME BLOCCANTI DEI CANALI AL CLORO VOLTAGGIO-DIPENDENTI CLC-K 77
Tissue specific action of the 2-(propyl)-1,4-benzoxazine on pancreatic beta cell ATP-sensitive potassium channels 75
Dimeric analogs of the dual PPARα/γ agonist LT-175: design, synthesis and biological evaluation. 74
Selective oxidation of Nitrogen organic compounds by Ruthenium tetroxide 73
Enantioselective properties of Penicillin G Acylase: Liquid Crhomatographic studies end docking simulations 73
MOLECULAR SPATIAL GEOMETRY OF CLC-K LIGANDS: OPTIMAL REQUIREMENTS TOWARDS HIGH AFFINITY CHANNEL BLOCK. 72
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW ANALOGS OF THE DUAL PPARα/γ AGONIST LT175. 70
H-1-NMR determination of the enantiomeric excess of the antiarrhythmic drug Mexiletine by using mandelic acid analogues as chiral solvating agents 70
Oxidation of tertiary polycyclic amines by RuO4 67
null 66
NEW CHIRAL CLOFIBRIC ACID ANALOGS AS LIGANDS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) alpha AND gamma 65
Design, synthesis and biological evaluation of a dimeric analog of the dual PPARα/γ agonist 2-(4-phenyl-phenoxy)-3-phenyl-propanoic acid. 63
Progettazione e sintesi di nuovi agenti antimicrobici e studio dell'attività biologica in associazione con differenti olii essenziali 62
Determinanti Molecolari della Selettività di Recettori Nucleari: Analisi Chemiometrica e Docking di Agonisti Selettivi di Recettori PPARs 62
EFFETTI DERIVANTI DALL'INTRODUZIONE DI SOSTITUENTI SUL NUCLEO DIFENILICO DEL COMPOSTO LT175, AGONISTA DUALE DEI RECETTORI NUCLEARI PPARalfa E PPARgamma 62
Molecular spatial geometry of CLC-K ligands: optimal requirements towards high affinity channel block 61
Effetti sulla conduttanza dei canali al cloro della muscolatura scheletrica indotti dall’introduzione di un sostituente arilossialchilico in a alla funzione carbossilica dell’acido 4-cloro-fenossiacetico 61
Traduzione Capitoli 1-9 56
null 56
Novel dual PPARalpha/gamma Agonists, as hypoglycemic and antidiabetic agents 56
NEW CHIRAL DERIVATIVES OF 2-(4-PHENYL-PHENOXY)-3-PHENYLPROPANOIC ACID WITH PPARalpha/gamma DUAL ACTIVITY. 55
Synthesis and biological screening of new chiral a-aryloxy-alkanoic acids as PPARs agonists 55
Design, synthesis and biological evaluation of a dimeric analog of the dual PPARα/γ agonist 2-(4-phenyl-phenoxy)-3-phenyl-propanoic acid 55
Effects on skeletal muscle chloride channel conductance of a-aryloxyalkyl-4-chlorophenoxyacetic acids 54
Evaluation of biophysical and pharmacological properties of chloride channels belonging to ClC family by the use of chiral clofibric acid derivatives 54
Synthesis and biological evaluation of new fluorinated analogues with PPARα and PPARγ agonist activity 52
Synthesis and biological screening of new chiral fibrates as potential PPAR α/γ dual agonists 51
Dal brodo primordiale alla farmacogenomica 50
Synthesis and biological screening of new chiral 2-(4-chloro-phenoxy)-3-phenylpropanoic acid analogs as potential PPAR alpha/gamma dual agonists 50
Molecular spatial geometry of CLC-K ligands: optimal requirements towards high affinity channel block 49
Molecular spatial geometry of CLC-K ligands: optimal requirements towards high affinity channel block 48
Novel imidazoline compounds as partial or full agonists of D2-like dopamine receptors inspired by I2-imidazoline binding sites ligand 2-BFI 48
Dimeric analogs of the dual PPARα/γ agonist LT-175: design, synthesis and biological evaluation 45
sintesi di una nuova serie di acidi 2-benzofuran-carbossilici e valutazione della loro attività bloccante dei canali al cloro voltaggio-dipendenti CLC-K 44
EVALUATION OF BIOPHYSICAL AND PHARMACOLOGICAL PROPERTIES OF CHLORIDE CHANNELS BELONGING TO CLC FAMILY BY THE USE OF CHIRAL CLOFIBRIC ACID DERIVATIVES. 41
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW ANALOGS OF THE DUAL PPARalpha/gamma AGONIST LT175 41
PROGETTAZIONE, SINTESI E VALUTAZIONE BIOLOGICA DI DERIVATI OSSIMMINICI AD ATTIVITA’ AGONISTA DUALE PPARα/γ. 40
MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY: CHEMIOMETRIC ANALYSIS AND DOCKING OF DUAL PPAR AGONISTS. 39
null 38
null 37
null 37
Synthesis, biological evaluation and molecular modeling investigation of fibrates analogues with PPARalpha945; and PPARgamma47; agonist activity 36
Sintesi e valutazione dell’attivita' agonista sui Peroxisome Proliferator-Activated Receptors (PPARs) di una nuova serie di derivati dell’acido 2-fenossi-3-fenil-propanoico 36
Ureidofibrate-like analogs as PPARgamma Agonists endowed with anti-proliferative activity 35
null 32
null 30
null 30
null 29
null 27
Synthesis and preliminary biological evaluation on PPARs of new ureidofibrate-like analogs 26
null 25
null 25
Totale 8.341
Categoria #
all - tutte 33.892
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.892


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021257 0 0 0 0 0 0 0 0 0 110 93 54
2021/2022601 23 89 1 22 25 23 29 28 24 27 119 191
2022/20231.064 185 68 60 93 140 146 10 110 214 4 14 20
2023/2024404 26 66 21 25 50 103 23 24 11 11 12 32
2024/20251.257 52 32 124 54 33 82 79 107 61 52 168 413
2025/20262.265 389 178 187 296 233 143 307 81 221 230 0 0
Totale 8.549